Introduction of a Phe377del Mutation in ANK Creates a Mouse Model for Craniometaphyseal Dysplasia
Open Access
- 1 July 2009
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 24 (7) , 1206-1215
Abstract
Craniometaphyseal dysplasia (CMD) is a monogenic human disorder characterized by thickening of craniofacial bones and flaring metaphyses of long bones. Mutations for autosomal dominant CMD have been identified in the progressive ankylosis gene ANKH. Previous studies of Ank loss-of-function models, Anknull/null and Ankank/ank mice, suggest that Ank plays a role in the regulation of bone mineralization. However, the mechanism for Ank mutations leading to CMD remains unknown. We generated the first knockin (KI) mouse model for CMD expressing a human mutation (Phe377 deletion) in ANK. Homozygous Ank knockin mice (AnkKI/KI) replicate many typical features of human CMD including hyperostosis of craniofacial bones, massive jawbones, decreased diameters of cranial foramina, obliteration of nasal sinuses, fusion of middle ear bones, and club-shaped femurs. In addition, AnkKI/KI mice have increased serum alkaline phosphatase and TRACP5b, as reported in CMD patients. Biochemical markers of bone formation and bone resorption, N-terminal propeptide of type I procollagen and type I collagen cross-linked C-terminal telopeptide, are significantly increased in AnkKI/KI mice, suggesting increased bone turnover. Interestingly, AnkKI/KI bone marrow–derived macrophage cultures show decreased osteoclastogenesis. Despite the hyperostotic phenotype, bone matrix in AnkKI/KI mice is hypomineralized and less mature, indicating that biomechanical properties of bones may be compromised by the Ank mutation. We believe this new mouse model will facilitate studies of skeletal abnormalities in CMD at cellular and molecular levels.Keywords
This publication has 42 references indexed in Scilit:
- Null mutations in human and mouse orthologs frequently result in different phenotypesProceedings of the National Academy of Sciences, 2008
- Expression and Localisation of the Pyrophosphate Transporter, ANK, in Murine Kidney CellsCellular Physiology and Biochemistry, 2007
- Increased Myeloid Cell Responses to M-CSF and RANKL Cause Bone Loss and Inflammation in SH3BP2 “Cherubism” MiceCell, 2007
- Biochemical and Genetic Analysis of ANK in Arthritis and Bone DiseaseThe American Journal of Human Genetics, 2006
- Craniometaphyseal and craniodiaphyseal dysplasia, head and neck manifestations and managementThe Journal of Laryngology & Otology, 1996
- Bone Scan Findings in Craniometaphyseal DysplasiaClinical Nuclear Medicine, 1993
- Bone marrow-derived osteoclast-like cells from a patient with craniometaphyseal dysplasia lack expression of osteoclast-reactive vacuolar proton pump.Journal of Clinical Investigation, 1993
- Craniometaphyseal dysplasia with increased bone turnover and secondary hyperparathyroidism: Therapeutic effect of calcitoninThe Journal of Pediatrics, 1988
- Treatment of craniometaphyseal dysplasia with calcitriolThe Journal of Pediatrics, 1988
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987